U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5004150041Stereotactic Body Radiotherapy for Unresectable Hepatocellular CarcinomaRecruitingNo Results AvailableLocalized Non-Resectable Adult Hepatocellular CarcinomaRadiation: Stereotactic body radiotherapyhttps://ClinicalTrials.gov/show/NCT01910909
5004250042Effectiveness and Safety Study of Overnight Intensive Patch in ScarsCompletedNo Results AvailablePost Dermatological Surgery ScarsDevice: Overnight Intensive Patchhttps://ClinicalTrials.gov/show/NCT01910896
5004350043Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: Finafloxacin i.v. solution 200 mg|Drug: Finafloxacin i.v. solution 400 mg|Drug: Finafloxacin i.v. solution 600 mg|Drug: Finafloxacin i.v. solution 800 mg|Drug: Finafloxacin i.v. solution 1000 mg|Drug: Placebo i.v. solutionhttps://ClinicalTrials.gov/show/NCT01910883
5004450044Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and TaxanesRecruitingNo Results AvailableMetastatic Breast CancerDrug: Cisplatin|Drug: Metronomic Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT01910870
5004550045Improving Hypertension ControlCompletedNo Results AvailableHypertensionBehavioral: Lifestyle counselinghttps://ClinicalTrials.gov/show/NCT01910857
5004650046Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and TaxanesRecruitingNo Results AvailableMetastatic Breast CancerDrug: Cisplatin|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT01910844
5004750047Study to Assess DerMend Moisturizing Bruise Formula in Improving the Appearance of Chronically Aged Forearms and HandsCompletedHas ResultsPurpuraDrug: DerMend Moisturizing Bruise Formulahttps://ClinicalTrials.gov/show/NCT01910831
5004850048Pilot Study of the Effect of Laser on Reversing Chronic Radiation InjuryRecruitingNo Results AvailableChronic Radiation DermatitisDevice: Fractional CO2 laser treatment|Other: No treatmenthttps://ClinicalTrials.gov/show/NCT01910818
5004950049Recent GDM Lifestyle InterventionRecruitingNo Results AvailableDiabetes Mellitus|Diabetes, GestationalBehavioral: Lifestyle and Risk Assessment classhttps://ClinicalTrials.gov/show/NCT01910805
5005050050Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass SurgeryRecruitingNo Results AvailableVitamin D Deficiency|Gastrointestinal DiseasesDevice: UV lamp|Device: UV lamphttps://ClinicalTrials.gov/show/NCT01910792
5005150051Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic ShocksRecruitingNo Results AvailableAtrial Fibrillation|CardioversionProcedure: 100 joule as first biphasic shock energy|Procedure: 120 joule as first biphasic shock energyhttps://ClinicalTrials.gov/show/NCT01910779
5005250052Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary SyndromeCompletedNo Results AvailablePolycystic Ovary SyndromeDrug: Coenzyme Q10|Drug: clomiphene citratehttps://ClinicalTrials.gov/show/NCT01910766
5005350053Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer PopulationRecruitingNo Results AvailableNeck CancerProcedure: APAhttps://ClinicalTrials.gov/show/NCT01910753
5005450054Mobility in Older PeopleActive, not recruitingNo Results AvailableFrail Older People Undergoing Inpatient RehabilitationOther: Enhanced Physical Activity|Other: Usual Care|Other: Social Interactionhttps://ClinicalTrials.gov/show/NCT01910740
5005550055Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian YouthActive, not recruitingNo Results AvailableDiabetesBehavioral: Together on Diabetes-Hopkinshttps://ClinicalTrials.gov/show/NCT01910727
5005650056Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache YouthCompletedNo Results AvailableHIV/AIDSBehavioral: Focus On Youth|Behavioral: Health Education Control Conditionhttps://ClinicalTrials.gov/show/NCT01910714
5005750057Extension Study of the Family Spirit ProgramRecruitingNo Results AvailableParentingBehavioral: Family Spirithttps://ClinicalTrials.gov/show/NCT01910701
5005850058Use of Radiofrequency Ablation for RGB SalvageActive, not recruitingNo Results AvailableObesityDevice: RFA treatmenthttps://ClinicalTrials.gov/show/NCT01910688
5005950059PCC and Fibrinogen Compared With FFP in PPHRecruitingNo Results AvailablePostpartum HaemorrhageDrug: PCC|Drug: FFPhttps://ClinicalTrials.gov/show/NCT01910675
5006050060Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)CompletedNo Results AvailableDermatitisOther: KLH 0.1 mg|Other: KLH 5 mg|Other: PBS (0.1 mL)|Other: Tuberculin PPDhttps://ClinicalTrials.gov/show/NCT01910662
5006150061A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of AdmiActive, not recruitingNo Results AvailableMuscular DystrophiesDrug: Drisapersenhttps://ClinicalTrials.gov/show/NCT01910649
5006250062Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV InfectionCompletedHas ResultsHepatitis CDrug: Sofosbuvir|Drug: RBVhttps://ClinicalTrials.gov/show/NCT01910636
5006350063Long-Term Quality of Life in Patients With Acute Promyelocytic LeukemiaCompletedNo Results AvailableAcute Promyelocytic LeukemiaOther: Health Related Quality of Life (HRQOL) measureshttps://ClinicalTrials.gov/show/NCT01910623
5006450064Multi-Line Therapy Trial in Unresectable Metastatic Colorectal CancerRecruitingNo Results AvailableColorectal Cancer MetastaticBiological: FOLFIRI-cetuximab|Biological: mFOLFOX6-bevacizumab|Biological: OPTIMOX-bevacizumab|Biological: irinotecan-based chemo + bevacizumab|Biological: Anti-EGFR agent (cetuximab +/- irinotecan or panitumumab)|Biological: XELOX + bevacizumabhttps://ClinicalTrials.gov/show/NCT01910610
5006550065Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid TumorsNot yet recruitingNo Results AvailableAdvanced Solid TumorsDrug: SBGhttps://ClinicalTrials.gov/show/NCT01910597
5006650066Quality of Life and Sexual Function of the Novasure Endometrial Ablation in MenorrhagiaRecruitingNo Results AvailableQuality of Life|Sexual ActivityProcedure: Novasure endometrial ablationhttps://ClinicalTrials.gov/show/NCT01910584
5006750067Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese SubjectsCompletedNo Results AvailableHealthyDrug: P7435|Other: Placebohttps://ClinicalTrials.gov/show/NCT01910571
5006850068The Effect of Oral Alpha-Cyclodextrin on Fecal Fat ExcretionActive, not recruitingNo Results AvailableObesity|Cardiovascular DiseaseDietary Supplement: Alpha-cyclodextrin and digestible starch|Dietary Supplement: Alpha-cyclodextrin|Dietary Supplement: Digestible starchhttps://ClinicalTrials.gov/show/NCT01910558
5006950069Phase 1 Study of OTS167 in Patients With Solid TumorsRecruitingNo Results AvailableSolid Tumors|Metastatic TumorsDrug: OTS167IVhttps://ClinicalTrials.gov/show/NCT01910545
5007050070The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive TherapyWithdrawnNo Results AvailableHypertensionDrug: Clevidipinehttps://ClinicalTrials.gov/show/NCT01910532

* Görseller ve İçerik tekif hakkına sahip olabilir